Get startedLog in
    Picture of Larimar Therapeutics logo

    LRMR — Larimar Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    All News

    Brief: Larimar Therapeutics Q2 Net Income USD -26.182 Million

    Picture of Larimar Therapeutics logoLarimar Therapeutics
    14/08/2025 12:00
    Aug 14 (Reuters) - Larimar Therapeutics Q2 operating expenses USD 27.792 million.

Q2 basic EPS USD -0.41

Q2 income from operations USD -27.792 million

Q2 EPS USD -0.41

    Recent news on Larimar Therapeutics

    See all news